Concurrent validity of the addiction severity index

Area of Science:

• Addiction Medicine
• Psychometrics
• Clinical Psychology

Background:

• The Addiction Severity Index (ASI) is a novel scale designed to evaluate multiple clinical dimensions in individuals with substance use disorders.
• Independent validation is crucial for establishing the reliability and utility of assessment tools in clinical practice.

Purpose of the Study:

• To evaluate the concurrent validity of the Addiction Severity Index (ASI) in a population of opiate addicts seeking treatment.
• To assess the ASI's ability to identify psychiatric comorbidities, specifically depression, in this patient group.

Main Methods:

• The study involved 204 opiate-addicted patients admitted for treatment.
• Concurrent validity was assessed by comparing ASI subscale scores with self-report measures.
• Diagnostic accuracy for depression was determined using sensitivity and specificity analyses. Cluster analysis was employed to explore scale discrimination.

Main Results:

• The ASI demonstrated good concurrent validity for psychological, social adjustment, legal, and employment problems (r = .55 to .39).
• Limited concurrent validity was observed for drug abuse problems; medical problems were not assessed.
• The ASI effectively identified addicts with psychiatric diagnoses beyond opiate abuse, particularly depression (89% sensitivity, 67% specificity).
• Cluster analysis revealed the ASI scales could differentiate between depressed, antisocial, and psychiatrically healthy addicts.

Conclusions:

• The Addiction Severity Index (ASI) is a valid instrument for assessing key clinical domains in opiate addicts.
• The ASI shows promise as an important tool for the comprehensive evaluation of opiate-dependent individuals in treatment settings.